[{"orgOrder":0,"company":"INMUNOVA","sponsor":"Exeltis | Chemo Research | Linical | KLIXAR","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"ARGENTINA","productType":"Antibody, Unconjugated","year":"2024","type":"Inapplicable","leadProduct":"INM004","moa":"Shiga Toxin","graph1":"Hematology","graph2":"Phase III","graph3":"INMUNOVA","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Infusion","sponsorNew":"INMUNOVA \/ Exeltis | Chemo Research | Linical | KLIXAR","highestDevelopmentStatusID":"10","companyTruncated":"INMUNOVA \/ Exeltis | Chemo Research | Linical | KLIXAR"},{"orgOrder":0,"company":"INMUNOVA","sponsor":"KLIXAR | Linical | PHV LATAM","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"ARGENTINA","productType":"Antibody, Unconjugated","year":"2022","type":"Inapplicable","leadProduct":"INM004","moa":"Shiga Toxin","graph1":"Gastroenterology","graph2":"Phase II","graph3":"INMUNOVA","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Infusion","sponsorNew":"INMUNOVA \/ KLIXAR | Linical | PHV LATAM","highestDevelopmentStatusID":"8","companyTruncated":"INMUNOVA \/ KLIXAR | Linical | PHV LATAM"},{"orgOrder":0,"company":"INMUNOVA","sponsor":"Exeltis","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"ARGENTINA","productType":"Antibody, Unconjugated","year":"2019","type":"Inapplicable","leadProduct":"INM004","moa":"Shiga Toxin","graph1":"Infections and Infectious Diseases","graph2":"Phase II\/ Phase III","graph3":"INMUNOVA","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Infusion","sponsorNew":"INMUNOVA \/ Exeltis","highestDevelopmentStatusID":"9","companyTruncated":"INMUNOVA \/ Exeltis"},{"orgOrder":0,"company":"INMUNOVA","sponsor":"Hospital Italiano de Buenos Aires","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"ARGENTINA","productType":"Antibody, Unconjugated","year":"2018","type":"Inapplicable","leadProduct":"INM004","moa":"Shiga Toxin","graph1":"Undisclosed","graph2":"Phase I","graph3":"INMUNOVA","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"INMUNOVA \/ Hospital Italiano de Buenos Aires","highestDevelopmentStatusID":"6","companyTruncated":"INMUNOVA \/ Hospital Italiano de Buenos Aires"},{"orgOrder":0,"company":"INMUNOVA","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"ARGENTINA","productType":"Protein","year":"2020","type":"Inapplicable","leadProduct":"INM005","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase II\/ Phase III","graph3":"INMUNOVA","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Infusion","sponsorNew":"INMUNOVA \/ Undisclosed","highestDevelopmentStatusID":"9","companyTruncated":"INMUNOVA \/ Undisclosed"}]